HB3637 - 104th General Assembly (2025-2026)

HEALTH REGULATION-VARIOUS
Last Action
8/22/2025 - House: Public Act . . . . . . . . . 104-0432
Statutes Amended In Order of Appearance
225 ILCS 6/60  
225 ILCS 15/15  from Ch. 111, par. 5365
225 ILCS 20/19  
225 ILCS 55/85  from Ch. 111, par. 8351-85
225 ILCS 60/22  from Ch. 111, par. 4400-22
225 ILCS 60/23  from Ch. 111, par. 4400-23
225 ILCS 64/100  
225 ILCS 65/65-65  was 225 ILCS 65/15-55
225 ILCS 65/70-5  was 225 ILCS 65/10-45
225 ILCS 85/30  from Ch. 111, par. 4150
225 ILCS 85/30.1  
225 ILCS 95/21  from Ch. 111, par. 4621
225 ILCS 107/80  
225 ILCS 120/55  from Ch. 111, par. 8301-55
225 ILCS 130/75  
225 ILCS 135/95  
410 ILCS 620/7  from Ch. 56 1/2, par. 507
410 ILCS 620/14  from Ch. 56 1/2, par. 514
410 ILCS 620/15  from Ch. 56 1/2, par. 515
Synopsis As Introduced
Amends the Behavior Analyst Licensing Act, the Clinical Psychologist Licensing Act, the Clinical Social Work and Social Work Practice Act, the Marriage and Family Therapy Licensing Act, the Medical Practice Act of 1987, the Licensed Certified Professional Midwife Practice Act, the Nurse Practice Act, the Pharmacy Practice Act, the Physician Assistant Practice Act of 1987, the Professional Counselor and Clinical Professional Counselor Licensing and Practice Act, the Wholesale Drug Distribution Licensing Act, the Registered Surgical Assistant and Registered Surgical Technologist Title Protection Act, and the Genetic Counselor Licensing Act. Provides that the Department of Professional and Financial Regulation shall not take any disciplinary or non-disciplinary action against a person's authorization to practice (rather than against the license or permit issued) under each of the amended Acts based solely upon the person's involvement in any health care service, so long as the care was not unlawful under the laws of the State. Prohibits the Department from taking any disciplinary or non-disciplinary action against a person's authorization to practice (rather than against the license or permit issued) under each of the amended Acts based upon the person's license, registration, or permit (rather than only license) being revoked or suspended, or the person being otherwise disciplined by any other state, if that form of discipline was based solely on the person violating another state's laws prohibiting involvement in any health care service if that health care service would not have been unlawful under the laws of the State and is consistent with the applicable standard of conduct for a person practicing in Illinois under those Acts. Changes certain references to official occupation titles in the amended Acts to "person". Amends the Illinois Food, Drug and Cosmetic Act. Provides that a drug's status as not approved by the U.S. Food and Drug Administration shall not cause it to be deemed an adulterated drug if its safety and efficacy have been established by peer-reviewed research or if it is recommended for use by the World Health Organization, even if the drug's labelling reflects prior approval that is no longer in effect, so long as such labelling was true and accurate at the time of manufacture.

House Floor Amendment No. 1
Provides that a drug's status as not approved by the U.S. Food and Drug Administration shall not cause it to be deemed an adulterated drug in violation of the Act if it is recommended for use by the World Health Organization (rather than if its safety and efficacy have been established by peer-reviewed research or if it is recommended for use by the World Health Organization).

Senate Committee Amendment No. 1
Provides that, if a drug had been approved by the U.S. Food and Drug Administration before January 1, 2025, the revocation of approval by the U.S. Food and Drug Administration shall not cause it to be deemed an adulterated drug in violation of the Illinois Food, Drug and Cosmetic Act if the drug is recommended for use by the World Health Organization, even if the drug's labeling reflects prior approval that is no longer in effect, so long as the drug's labeling was true and accurate at the time of its manufacture. Provides that those provisions are inoperative on and after January 1, 2035.
Actions
DateChamberAction
2/07/2025HouseFiled with the Clerk by Rep. Dagmara Avelar
2/18/2025HouseFirst Reading
2/18/2025HouseReferred to Rules Committee
3/11/2025HouseAssigned to Health Care Availability & Accessibility Committee
3/13/2025HouseAdded Co-Sponsor Rep. Joyce Mason
3/13/2025HouseAdded Co-Sponsor Rep. Nabeela Syed
3/13/2025HouseAdded Co-Sponsor Rep. Abdelnasser Rashid
3/13/2025HouseAdded Co-Sponsor Rep. Aarón M. Ortíz
3/13/2025HouseAdded Co-Sponsor Rep. Edgar González, Jr.
3/13/2025HouseAdded Co-Sponsor Rep. Barbara Hernandez
3/18/2025HouseAdded Co-Sponsor Rep. Nicolle Grasse
3/18/2025HouseAdded Co-Sponsor Rep. Anna Moeller
3/18/2025HouseAdded Co-Sponsor Rep. Lindsey LaPointe
3/18/2025HouseAdded Co-Sponsor Rep. Margaret Croke
3/18/2025HouseAdded Co-Sponsor Rep. Eva-Dina Delgado
3/18/2025HouseAdded Co-Sponsor Rep. Kimberly Du Buclet
3/18/2025HouseAdded Co-Sponsor Rep. Yolonda Morris
3/18/2025HouseAdded Co-Sponsor Rep. Jennifer Gong-Gershowitz
3/18/2025HouseAdded Co-Sponsor Rep. Sharon Chung
3/18/2025HouseAdded Co-Sponsor Rep. Will Guzzardi
3/18/2025HouseAdded Co-Sponsor Rep. Mary Beth Canty
3/18/2025HouseAdded Chief Co-Sponsor Rep. Kelly M. Cassidy
3/18/2025HouseAdded Chief Co-Sponsor Rep. Jehan Gordon-Booth
3/18/2025HouseAdded Chief Co-Sponsor Rep. Robyn Gabel
3/18/2025HouseAdded Chief Co-Sponsor Rep. Bob Morgan
3/18/2025HouseDo Pass / Short Debate Health Care Availability & Accessibility Committee; 009-005-000
3/19/2025HouseAdded Co-Sponsor Rep. Michael Crawford
3/19/2025HousePlaced on Calendar 2nd Reading - Short Debate
3/19/2025HouseHouse Floor Amendment No. 1 Filed with Clerk by Rep. Dagmara Avelar
3/19/2025HouseHouse Floor Amendment No. 1 Referred to Rules Committee
3/20/2025HouseHouse Floor Amendment No. 1 Rules Refers to Health Care Availability & Accessibility Committee
3/25/2025HouseHouse Floor Amendment No. 1 Recommends Be Adopted Health Care Availability & Accessibility Committee; 008-003-000
3/26/2025HouseSecond Reading - Short Debate
3/26/2025HouseHeld on Calendar Order of Second Reading - Short Debate
4/07/2025HouseHouse Floor Amendment No. 1 Adopted by Voice Vote
4/07/2025HousePlaced on Calendar Order of 3rd Reading - Short Debate
4/07/2025HouseAdded Co-Sponsor Rep. Maura Hirschauer
4/07/2025HouseAdded Co-Sponsor Rep. Janet Yang Rohr
4/07/2025HouseThird Reading - Short Debate - Passed 067-039-000
4/07/2025HouseAdded Co-Sponsor Rep. Natalie A. Manley
4/08/2025SenateArrive in Senate
4/08/2025SenatePlaced on Calendar Order of First Reading
4/08/2025SenateChief Senate Sponsor Sen. Karina Villa
4/08/2025SenateFirst Reading
4/08/2025SenateReferred to Assignments
4/23/2025SenateAssigned to Executive
4/30/2025SenateAdded as Alternate Co-Sponsor Sen. Sara Feigenholtz
5/02/2025SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Karina Villa
5/02/2025SenateSenate Committee Amendment No. 1 Referred to Assignments
5/06/2025SenateSenate Committee Amendment No. 1 Assignments Refers to Executive
5/09/2025SenateRule 2-10 Committee Deadline Established As May 23, 2025
5/14/2025SenateAdded as Alternate Co-Sponsor Sen. Omar Aquino
5/14/2025SenateSenate Committee Amendment No. 1 Adopted
5/15/2025SenateDo Pass as Amended Executive; 008-004-000
5/15/2025SenatePlaced on Calendar Order of 2nd Reading
5/15/2025SenateSecond Reading
5/15/2025SenatePlaced on Calendar Order of 3rd Reading May 20, 2025
5/16/2025SenateAdded as Alternate Co-Sponsor Sen. Mike Simmons
5/20/2025SenateAdded as Alternate Co-Sponsor Sen. Mary Edly-Allen
5/21/2025SenateAdded as Alternate Co-Sponsor Sen. Rachel Ventura
5/22/2025SenateThird Reading - Passed; 038-019-000
5/23/2025HouseArrived in House
5/23/2025HousePlaced on Calendar Order of Concurrence Senate Amendment(s) 1
5/23/2025HouseSenate Committee Amendment No. 1 Motion Filed Concur Rep. Dagmara Avelar
5/23/2025HouseSenate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee
5/27/2025SenateAdded as Alternate Co-Sponsor Sen. Graciela Guzmán
5/28/2025HouseSenate Committee Amendment No. 1 Motion to Concur Rules Referred to Health Care Availability & Accessibility Committee
5/29/2025HouseSenate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Health Care Availability & Accessibility Committee; 008-004-000
5/29/2025HouseAdded Co-Sponsor Rep. Camille Y. Lilly
5/30/2025HouseChair Rules placed on Standard debate.
5/30/2025HouseAdded Co-Sponsor Rep. Amy Briel
5/30/2025HouseAdded Co-Sponsor Rep. Michelle Mussman
5/30/2025HouseAdded Co-Sponsor Rep. Laura Faver Dias
5/30/2025HouseSenate Committee Amendment No. 1 House Concurs 075-039-000
5/30/2025HouseHouse Concurs
5/30/2025HousePassed Both Houses
6/24/2025HouseSent to the Governor
8/20/2025SenateAdded as Alternate Co-Sponsor Sen. Paul Faraci
8/22/2025HouseGovernor Approved
8/22/2025HouseEffective Date January 1, 2026
8/22/2025HousePublic Act . . . . . . . . . 104-0432